Spotlights

Home/Spotlights

Spotlight Q&A with Rob Neville, CEO, Savara Pharmaceuticals

About Savara Pharmaceuticals: Savara Inc. (NASDAQ: SVRA) is an orphan lung disease company. Savara's pipeline comprises a number of late stage therapeutics each targeting difficult to treat lung diseases. Rob Neville CEO, Savara Pharmaceuticals For people not familiar with Savara, can you provide a brief overview and focus? Neville: Savara was founded in [...]

April 2nd, 2018|

Spotlight: Virginia Capezio from TriNet Talks About How Biotech Companies Can Tackle the Tough HR Considerations in 2018

Virginia Capezio is a senior human resources consultant with TriNet, a company that provides full-service HR solutions to small and midsize businesses. Here, Virginia talks about the changing landscape of the biotech workplace, how broader trends may be affecting the environment and the big HR issues biotech companies should be thinking about in the new [...]

January 8th, 2018|

Advancing Drug Development Forum – Making the Impossible Possible

Time: 08:30-19:30 Registration fees: Academic Attendee:  $195, General Attendee:  $395 Register here: Click here to register for this event   Forum description: Register for this ground-breaking inaugural event to explore new solutions, promising technology breakthroughs and how industry can introduce and incorporate improved approaches in drug development. The program, proudly sponsored by Juniper Pharma Services, [...]

November 10th, 2017|

From Candidate Selection to Market: Navigating Challenges in Biotechnology

  Not every drug development program follows a similar path to regulatory approval. Don’t miss out on this Charles River workshop which will bring together industry professionals to provide guidance on key components and considerations for designing and optimizing your drug development program. The workshop will include interactive sessions to discuss how to attract investors, [...]

October 10th, 2017|

Spotlight: Fostering a Culture of Innovation to Drive Growth

Develop an Innovative Culture As companies look to generate new growth, many are concerned that their culture may be inhibiting them from achieving their goals. While many people believe a stronger culture that supports innovation will lead to growth, most lack clarity about what the true impact improving culture has on innovation and what types [...]

September 27th, 2017|

Charles River 23rd Annual Biotechnology-Derived Therapeutics Perspectives on Nonclinical Development Symposium

The Charles River 23rd Annual Biotechnology-Derived Therapeutics Perspectives on Nonclinical Development symposium will be held September 11-13, 2017 at Cape Rey Resort, Carlsbad, CA. This three-day symposium with five sessions has a jam-packed agenda with case study presentations from industry leaders from Bluebird, Janssen, Pfizer and Amgen in the nonclinical development of biotherapeutics. Don’t miss out on [...]

July 24th, 2017|

Advancing Rare Disease Drug Discovery: Navigating the Path to an IND

Symposium Overview: Therapies to treat rare and undiagnosed diseases are in high demand in a favorable regulatory environment. Thus, it is critically important to optimize the discovery and development of such therapies by creating – and following – the most efficient path to an investigational new drug (IND) filing. How do we do just that? [...]

April 5th, 2017|

Spotlight: Every Challenge. Every Day. Every Voice.

Behind every patient stands thousands of scientists and researchers working together to develop life-saving treatments. So what happens when a patient meets the people that helped save her life? Watch this 8-minute documentary as Ginger Tam, a lung-cancer patient, meets the researchers who worked on her cancer treatment.    

March 1st, 2017|

Spotlight: Charles River Laboratories Acquires Agilux Laboratories, Inc.

Charles River has announced the acquisition of Agilux Laboratories, Inc., a Worcester, Massachusetts-based contract research organization (CRO) providing a suite of integrated discovery small- and large-molecule bioanalytical services, DMPK (drug metabolism and pharmacokinetics) and pharmacology services. Agilux has built an enviable reputation for flexibility and speed, offering in vivo PK (pharmacokinetics), in vitro ADME (absorption [...]

October 21st, 2016|
X